Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet StudyDaniela Cilloni, David Grimwade, Aline Renneville et al.|Journal of Clinical Oncology|2009Cited by 434
Transcriptional diversity during lineage commitment of human blood progenitorsLu Chen, Asif U. Tamuri, Myrto Kostadima et al.|Science|2014Cited by 311
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 TrialR. Willemze, Théo de Witte, Stefan Suciu et al.|Journal of Clinical Oncology|2013Cited by 168
Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasmsHideki Makishima, Jaroslaw P. Maciejewski, Yuichi Shiraishi et al.|Blood|2022Cited by 142
CLPB Mutations Cause 3-Methylglutaconic Aciduria, Progressive Brain Atrophy, Intellectual Disability, Congenital Neutropenia, Cataracts, Movement DisorderSaskia B. Wortmann, Ron A. Wevers, Szymon Ziętkiewicz et al.|The American Journal of Human Genetics|2015Cited by 135